News & Analysis as of

Center for Drug Evaluation and Research (CDER) Pharmaceutical Industry Patient Protection and Affordable Care Act (PPACA)

Holland & Knight LLP

Holland & Knight Health Dose: January 21, 2026

Holland & Knight LLP on

The U.S. Senate is out of session this week, and all action is expected to take place in the U.S. House of Representatives following the release of a package containing the final four appropriations bills. The text of the...more

Holland & Knight LLP

Holland & Knight Health Dose: November 4, 2025

Holland & Knight LLP on

This week, the government shutdown entered its fifth week and, on Nov. 4, 2025, became the longest in history, beating a 34-day-plus record set during President Donald Trump's first term. Meanwhile, the Open Enrollment Period...more

2 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide